The aim of this study was to evaluate three different metabolite prediction software packages (Meteor, MetaSite, and StarDrop) with respect to their ability to predict loci of metabolism and suggest relative proportions of metabolites. A chemically diverse test set of 22 compounds, for which in vivo human mass balance studies and metabolic schemes were available, was used as basis for the evaluation. Each software package was provided with structures of the parent compounds, and predicted metabolites were compared with experimentally determined human metabolites. The evaluation consisted of two parts. First, different settings within each software package were investigated and the software was evaluated using those settings determined to give the best prediction. Second, the three different packages were combined using the optimized settings to see whether a synergistic effect concerning the overall metabolism prediction could be established. The performance of the software was scored for both sensitivity and precision, taking into account the capabilities/limitations of the particular software. Varying results were obtained for the individual packages. Meteor showed a general tendency toward overprediction, and this led to a relatively low precision (ϳ35%) but high sensitivity (ϳ70%). MetaSite and StarDrop both exhibited a sensitivity and precision of ϳ50%. By combining predictions obtained with the different packages, we found that increased precision can be obtained. We conclude that the state-ofthe-art individual metabolite prediction software has many advantageous features but needs refinement to obtain acceptable prediction profiles. Synergistic use of different software packages could prove useful.
Introduction
In drug discovery, the metabolism of a drug compound is one of the key parameters to be investigated and optimized to obtain acceptable pharmacokinetic and/or safety profiles. In development, early prediction of relevant metabolites before introduction of the drug compound into man would substantially help preclinical and clinical development concerning the analysis of (phase I and/or II) metabolism data and decision making (Afzelius et al., 2007; Van Campen, 2009) .
A variety of different approaches to predict drug metabolism have been described: rule-, ligand-protein-, and ligand-based methods (Cruciani et al., 2005; Tarcsay and Keseru, 2011) . Other approaches include ab initio, classic pharmacophore, and three-dimensional quantitative structure-activity relationship pharmacophore-based methods (Testa, 2004; Cruciani et al., 2005; Czodrowski et al., 2009 ). Unfortunately, obstacles such as biological factors and substrate-product selectivity still hinder the widespread use of drug metabolism as a reliable tool (Testa, 2004) .
Here, we describe the evaluation of three software tools: Meteor (Lhasa Ltd., Leeds, UK), MetaSite (Molecular Discovery Ltd., Middlesex, UK), and StarDrop (Optibrium Ltd., Cambridge, UK). We have chosen these tools because they are currently being used in both the discovery and development phases of the pharmaceutical industry and each tool is based on a different approach to predict metabolism. A comparison of the software packages is contained in Table 1 .
Meteor is a rule-based (empirical) software tool (Langowski and Long, 2002) . Its algorithm involves three successive steps. First, Meteor checks whether the query structure contains substructures that are labile toward any of the biotransformations contained in its knowledge base. Second, absolute reasoning rules evaluate the likelihood of a biotransformation taking place based on five levels: probable, plausible, equivocal, doubted, and improbable (Button et al., 2003) . This classification depends on the logP of the query structure, whether the query structure is the unchanged drug or a metabolite, and in which species the metabolism is to be predicted. Third, relative reasoning then is used to rank those biotransformations that can occur concomitantly on the same compound, based on a set of relative precedences (e.g., primary alcohols are oxidized in preference to secondary alcohols). Relative reasoning can be set at 0, 1, 2, 3 and can only be used when two or more biotransformations apply for the same compound: RRL0 means that no relative reasoning will be applied in the upcoming analysis; RRL1 means that only metabolites will be displayed for which there is no metabolite more likely (i.e., most likely); RRL2 means that most likely metabolites, and metabolites for which there is only one level of metabolites more likely, will be displayed. In essence, the reasoning engine uses further rules to avoid a combinatorial explosion of output resulting from unconstrained analyses of query structures (Ekins et al., 2007) .
MetaSite is an automated docking model with reactivity correction (this correction considers the reactivity components of an atom related to the heme) and is designed to predict phase I cytochrome P450 (P450) metabolism. Based on GRID descriptors for the P450 enzymes and the potential substrate (Cruciani et al., 2005) , metabolism is evaluated at all possible sites on the molecular structure, assigning every atom a likelihood of metabolism. Reactivity correction can be put in three different modes: 1) "off"; 2) "on for substrate"; and 3) "on for substrate and CYP" (Cruciani et al., 2005; Zhou et al., 2006; Vaz et al., 2010) .
StarDrop uses a quantum mechanical approach for the prediction of the relative involvement of CYP3A4, 2D6, and 2C9 of the query compound. Its mechanism is based on calculation of the energy barrier to the electron removal, which is considered to be the rate-limiting step in product formation. All of the modeled P450 isoforms use the same model for the calculation of electronic lability, but each isoform has a different model for steric accessibility and orientation effects (different regioselectivity) (Earnshaw, 2010) .
Metabolism prediction is scored using two performance parameters, sensitivity and precision, with the in vivo metabolic profile as a reference point. Sensitivity is a measure of how many in vivo metabolites are captured by the software; precision is a measure of how many predicted metabolites are actually observed in vivo (see Materials and Methods for a definition). Ideally, sensitivity as well as precision should be as high as possible for any given prediction. However, a prioritization of either sensitivity or precision will be necessary, depending on the scope of the intended research. Figure 1 correlates the location of a prediction result within each quadrant in the sensitivity/prediction plot with the value of the prediction result. In the Discussion, we will further comment on the usefulness of the prediction result in drug discovery and development.
Materials and Methods
The In Vivo Reference Set. The goal of most in silico models is to predict what cannot directly be measured. In this project, the output of the metabolism prediction software packages was compared with the known metabolite profile obtained after administration in man. To understand the most important metabolic clearance pathways of a compound, the mass balance of the parent and its metabolites was determined in excreta after a single oral dose. A test set of 22 compounds ( Fig. 2 For every compound in the set of test compounds, the report of the human absorption, metabolism, and excretion trial was abstracted to provide a table of observed metabolites. Finally, the primary, main metabolic pathways were collated, highlighting metabolites that were expected to be formed directly from the parent compound (illustrated in the supplemental data).
The reference set contained 68 (phase I P450, phase I non-P450, and phase II) primary biotransformation pathways. A list of these biotransformations can -37822681, N-[1-(3,4-difluorobenzyl)piperidin-4-yl]-6-(trifluoromethyl) pyridazin-3-amine; R228060, 2-amino-3-phenylpropyl carbamate; JNJ-31001074, 4-{4-[(4-cyclopropylpiperazin-1-yl)carbonyl]benzyl}morpholine; ADHD, attention deficit hyperactivity disorder.
a Carbamate hydrolysis is considered as ester hydrolysis by esterases. b GSH conjugation is considered phase II.
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at ASPET Journals on April 3, 2017 dmd.aspetjournals.org bridgeSoft, Cambridge, MA), and ISIS Draw (version 2.4; MDL Information Systems Inc., San Leandro, CA). Testing of Individual Software Packages. Both Meteor and MetaSite allow the user to customize the prediction settings. Only StarDrop had no selectable settings. The outcome of each of the various settings investigated was evaluated, and these different outcomes were compared with the in vivo data. The goal of this software-per-software exercise was to 1) find which settings provided the best prediction for a given software package (INTRA), 2) compare the three software packages to each other using their optimized settings (INTER), and 3) investigate whether there was any added prediction value in combining the outcomes of individual software packages (illustrated in the supplemental data).
Meteor. Each chemical structure was imported, and predictions were performed using each possible setting [absolute reasoning level (ARL) and relative reasoning level (RRL)]. Absolute reasoning was tested only at the "probable" and "plausible" levels. Relative reasoning was tested on levels 0, 1, and 2 for each absolute reasoning level. The outcomes for these six different setting combinations were compared with 68 in vivo biotransformations from the reference data. From now on, when quoting a setting in Meteor, we will use the format "ARL RRL" (e.g., "plausible 1").
Meteor predicts biotransformations rather than metabolic hotspots. This is because per locus of metabolism, several metabolites can be formed. For example, following N-dealkylation, three metabolites are formed in silico: an amine, an alcohol, and further downstream oxidation of the alcohol to the acid. This complicates the comparison of the three packages, because where MetaSite or StarDrop would predict one site of metabolism correlating with Ndealkylation, Meteor would predict three metabolites.
MetaSite. Each chemical structure was imported into the software, and a prediction of hotspots was performed. MetaSite allows the user to toggle between various reactivity settings post hoc. We have tested the settings "without reactivity correction," "with reactivity correction for the substrate," and "with reactivity correction for substrate and CYP." Only "most probable" and "intermediately probable" sites (correlating with relative percentage intervals [0.50; 1.00] and [0.25; 0.50], respectively) were considered. The metabolic hotspots obtained with these six different settings were compared with 50 in vivo P450 biotransformations from the reference data. From now on, when quoting a setting in MetaSite, we will use the format "considered SOM; reactivity correction setting" (e.g., "most probable and intermediately probable; on for substrate").
StarDrop. Each chemical structure was imported into the software, and a prediction of metabolism was performed. StarDrop had no user-adaptable settings. Only "labile" and "moderately labile" positions were considered. The outcome was compared with 50 in vivo P450 biotransformations from the reference data.
Testing the Combination of Software Packages. The individual outcomes of the different software packages were also combined to examine whether this could increase the prediction reliability. Several combinational approaches were tested and reported using the following approaches (Table 3) .
Intersection. All three software packages predict P450 reactions; only Meteor also predicts phase I non-P450 and phase II reactions. Consequently, when evaluating which metabolites were predicted in common by the various packages, only P450 reactions were taken into account. This "intersection" approach was used with the following combinations: MeteorMetaSite; Meteor-StarDrop; and MetaSite-StarDrop.
Union. In the "union" approach, all the predictions that are made by each package are taken into account, including biotransformations that are predicted in common and biotransformations that are independently predicted by the software packages. We also investigated whether the different software packages were complementary to each other. By "complementary," we mean the prediction of independently predicted biotransformations of a certain software package that were not seen in common to the two software packages. The following combinations were made: Meteor-MetaSite; Meteor-StarDrop; and MetaSite-StarDrop.
Intersectionϩn. "Intersectionϩ2" was the approach used to combine results from Meteor and MetaSite: P450 biotransformations that were common to these two packages, together with additional phase I non-P450 and phase II predictions from Meteor. "Intersectionϩ3" was the approach used to combine results from Meteor, MetaSite, and StarDrop: P450 biotransformations common to 1) the three packages and 2) Meteor and MetaSite, Meteor and StarDrop, and MetaSite and StarDrop, together with additional phase I non-P450 and phase II predictions from Meteor.
Evaluation. Each prediction of a metabolite or biotransformation route was compared with the experimentally observed in vivo biotransformations by scoring a predicted metabolite or biotransformation route as "TRUE," "FALSE," or "MISSED."
In the case of binary classification of data (as in this case), performance testing parameters such as sensitivity, specificity, accuracy, and precision can be used. In the case of metabolism predictions compared with a reference set, accuracy and specificity cannot be used because the concept "true negative" (used to calculate accuracy and specificity) is not appropriate. A true negative would mean a metabolite NOT predicted in silico and NOT seen in vivo. This is an irrelevant situation in metabolism prediction, because one could then take any possible biotransformation, whether or not relevant to the query structure, into the comparison. For example, the human absorption, metabolism, and excretion report indicates that (Ϯ)-5-[{6-(2-fluorobenzyl)-oxy-2-naphthyl}methyl]-2,4-thiazolidinedione (RWJ-241947) is not acetylated in vivo (supplemental data). RWJ-241947 acetylation is also not predicted in silico. Thus, acetylation would be a true negative. Nevertheless, true negatives do not make any sense in the evaluation of the performance of a metabolism prediction package. Our prediction quality assessment was then as follows: true positive, a metabolite predicted and also seen in vivo was assigned the value TRUE; false positive, a metabolite predicted but NOT seen in vivo was assigned the value FALSE; false negative, a metabolite NOT predicted but seen in vivo was assigned the value MISSED.
Precision describes the proportion of correctly predicted metabolites in the population of all in silico metabolites of a test compound, and is defined as follows: precision ϭ true positives/(true positives ϩ false positives) ϫ 100%.
Sensitivity describes the ability of a system to predict a TRUE metabolite in the population of all in vivo metabolites of a certain test compound and is defined as follows: sensitivity ϭ true positives/(true positives ϩ false negative) ϫ 100%.
Results
Results for the Individual Software Packages. Meteor. Meteor was tested at six different settings: the ARL at probable with RRL 0, 
Overview of combinations of software packages evaluated in this study
The first column describes the type of combination, and remaining columns indicate which software setting was used to obtain the combination outcome. 1, and 2; and the ARL at plausible with RRL 0, 1, and 2. For each of these settings, the absolute amounts of TRUE, FALSE, and MISSED biotransformations are shown in Fig. 3 . The influence of the parameter settings is best visualized through a precision versus sensitivity plot (Fig. 4) . Using the probable level, the sensitivity is ϳ20% (20% of the experimentally observed metabolites are correctly predicted) with a precision of ϳ40% (40% of the predicted metabolites are actually observed in vivo). In the plausible level, the precision lowers a few percentage points, but there is a very substantial increase in sensitivity. Indeed, when moving from probable to plausible, many of the MISSED metabolites (not predicted, although experimentally observed) from the probable level do become TRUE metabolites (predicted and observed) in the plausible level.
Relative reasoning levels constrain the prediction output. The lower the relative reasoning level, the more restriction there is. The result of this constraint is exemplified in Fig. 4 , where a decrease in RRL (RRL 1 compared with RRL 2) is associated with a strong decrease in sensitivity (especially at plausible absolute reasoning) and only a small increase in precision. That is to say, constraining the prediction output (lower RRL) results in slightly more precise, yet less sensitive, results. With the relative reasoning set to off (RRL ϭ 0) we can isolate the effect of the absolute reasoning filter. In Fig. 4 
Sensitivity Precision
The outcomes for the individual settings for Meteor 
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MetaSite. Reactivity correction in MetaSite can be set to 1) off, 2) on for substrate, and 3) on for substrate and CYP. We evaluated these three settings for both most probable and "most probable and intermediately probable" sites of metabolism (SOM), resulting in six different outcomes.
With the reactivity correction removed, precision is at its lowest (Fig. 5) at ϳ20%. When considering most probable and intermediately probable SOMs, the differences in sensitivity and precision between settings on for substrate and on for substrate and CYP are minimal. In Fig. 5 , the gray and especially the black arrow indicates that, when moving from most probable to most probable and intermediately probable, the gain in sensitivity is accompanied by a loss in precision. Of course, also reactivity correction largely affects the sensitivity and precision (compare results 1 3 3 3 5).
The best predictions in MetaSite (combination of the highest sensitivity with the highest precision) were obtained when considering only the most probable metabolites and using reactivity correction enabled for substrate.
StarDrop. We considered those hotspots considered to be labile and moderately labile positions, respectively, for each of the different SOMs for each query compound. Because StarDrop has no userselectable settings, the prediction quality plot (Fig. 5) has only one outcome with precision of ϳ45% and sensitivity of ϳ51%, which is comparable with the best outcome obtained with MetaSite.
Results for the Combinations of Software Packages. The quality plots for software combinations, Figs. 6 (P450 predictions only) and 7 (phase I and phase II predictions) show 1) the optimum outcomes per individual software package (as described in the above sections) and 2) the outcomes of a combination of software packages (as described: intersection, union, and intersectionϩn). The results are again based on the combined outcomes for all 22 compounds in the reference set, resulting in a single scatter plot entry per setting or software combination.
In Fig. 6 , the black arrow indicates that when moving from the best setting in MetaSite to the combination of MetaSite in its best setting with Meteor "plausible 0," a great increase in prediction precision is found. The white arrow suggests the same, but for the combination of StarDrop with Meteor plausible 0. Using the intersection approach for P450 predictions (Fig. 6) , precision can be increased by 20% with no reduction in sensitivity. The union result shows an increase in sensitivity but, again, a great loss in precision.
In Fig. 7 , the white arrow represents the evolution from the result for plausible 0 in Meteor toward the result for a union combination with MetaSite that is not useful; this union approach does not improve prediction quality compared with the individual outcomes for Meteor. The black arrow in Fig. 7 indicates the evolution toward the intersectionϩn approach, which resulted in an increase in precision of ϳ20%, with little or no decrease in sensitivity, compared with Meteor results plausible 0 and "plausible 2," respectively. Both intersectionϩ2 (based on the common P450 predictions of Meteor and MetaSite and the phase I non-P450 and phase II predictions from Meteor) and intersectionϩ3 (based on the common P450 predictions of Meteor, MetaSite, and StarDrop and the phase I non-P450 and phase II predictions from Meteor) provide nearly similar sensitivity (ϳ65%) and precision (ϳ55%) quality values.
Discussion
Optimal Individual Software Settings. Meteor in setting plausible 1 offered more precise, but less sensitive, predictions compared with the other five Meteor results (Fig. 4) . In contrast, settings plausible 2 (default setting) and plausible 0 (Meteor's most valuable setting) can be used to obtain more sensitive results. In our opinion the enhanced sensitivity is Meteor's most valuable feature. However, it remains to be seen whether this enhanced sensitivity is really an advantage, especially in a discovery setting. Rule-based software such as Meteor is known to show a tendency for overprediction (high sensitivity/low precision) of metabolism (Cruciani et al., 2005) , e.g., a piperidine moiety in a compound can undergo N-oxidation, but in another compound, the same piperidine moiety is oxidized on a carbon atom (lactam formation) of the heterocycle. Rule-based software that recognizes the piperidine moiety will generate these two metabolites (N-oxide and lactam). A high sensitivity/low precision is useless in lead optimization, because it is not able to guide the medicinal chemists. The high sensitivity denotes that a lot of information is there but cannot be used with sufficient certainty because of the low precision. However, this pattern should not pose any problem if the scope of the intended research is to actively look for metabolites. In the context of metabolite hunting or metabolite explanation, Meteor already proved useful in software-assisted detection of metabolites (Pelander et al., 2009; Naegele et al., 2010; Valerio and Long, 2010) . The most valuable outcome for MetaSite and StarDrop is highlighted in Fig. 5 . The overall prediction pattern of these software tools yields more precise, albeit less sensitive, predictions compared with Meteor. Therefore, in the elucidation of a compound's metabolites in early lead optimization and soft spot identification, StarDrop (Segall et al., 2009; Earnshaw, 2010) (http://www.optibrium.com/downloads) and MetaSite (Ahlström et al., 2007; Boyer et al., 2009; Trunzer et al., 2009; Myatt et al., 2010; Wu et al., 2010) are much more appropriate tools.
Combining Metabolite Prediction Software. The intersection combination of Meteor in the configuration plausible 0 with MetaSite in the configuration "most probable; on for substrate" enhances prediction reliability, because it provides a precision level practically unsurpassed by any other setting or combination (Fig. 6) . Again, this is at the expense of sensitivity. By applying the intersection approach, an increase in prediction precision is achieved by a reduction of false-positive predictions made by the software packages and underscores the added value of combining software packages that are based on quite different algorithms.
The union combination of MetaSite and StarDrop (Fig. 6) was not useful as such but could provide us with some valuable insights: a 
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at ASPET Journals on April 3, 2017 dmd.aspetjournals.org sensitivity of 65% is achieved by almost equal contributions of the two software tools, whereas in their intersection combination (Fig. 6) , sensitivity represented only 37% (meaning few biotransformations in common). This would imply that MetaSite and StarDrop are, to a certain degree, complementary to each other in predicting in vivo metabolism. The union combinations from Fig. 7 did not yield more precise nor more sensitive results compared with Meteor's best individual settings (plausible 0; plausible 2). By making the intersectionϩn combinations (sum of the common P450 predictions by two or three programs and the phase I non-P450 and phase II predictions from Meteor), we wanted to investigate how the prediction would be affected if Meteor supplied information only on phase I non-P450 and phase II predictions, whereas the precision in P450 predictions is maintained by using the intersection approach. This procedure fits in neatly with the concept of taking the positive aspects of each individual software package and trying to circumvent, as much as possible, their limitations. Figure 7 demonstrates that precision is increased by nearly 20% for Meteor, 15% for StarDrop, and 5% for MetaSite compared with the individual packages when used in isolation.
In a recently published review article (Tarcsay and Keseru, 2011) , the performance of metabolite prediction software was also assessed. When we compared our investigation results with the studies reviewed in this publication, we found that our prediction quality assessment points toward a substantially lower prediction quality compared with what these authors report. This could be due to the fact that a great difference in scoring methodology exists between both our studies. The studies mentioned by Tarcsay and Keseru (2011) report on scoring the accuracy of predictions (SOMs) of the different prediction tools based on the first, the first two, or the first three ranked predicted metabolites per software tool and per P450 isoform. In our article, we wanted to present a more generic approach, scoring the performance of the software outcome by letting it use its own constraints instead of the user choosing some cut-off value. We also wanted to evaluate the value of combining both oxidative and conjugative biotransformation predictions. We acknowledge the primary importance of P450-mediated metabolism, but reliable predictions of phase II metabolism are also of interest (Cubitt et al., 2011) .
Limitations and Pitfalls. An important remark is that although we consider the in vivo metabolite profile in human as the golden standard, this approach has some limitations. The metabolite profile may change as the dose level (saturation of processes) or extent of absorption (formulation dependent) changes, or when transporters affect the exposure of the compound to the metabolizing enzymes. However, similar concerns also apply when comparing the software outputs against in vitro metabolite profiles in liver microsomes or hepatocytes.
In Meteor, we found that there is no correlation between the absolute reasoning level of predicted metabolites and their abundance in vivo, irrespective of the terminology probable, plausible, etc. Because Meteor does not consider the shape of the molecule in making predictions, Meteor overemphasizes simple oxidations. Indeed, allowing Meteor to evaluate metabolic transformations down to the "equivocal" level results in completely indiscriminate hydroxylation. Finally, N-glucuronidations at amine moieties are often found in vivo for the test set, but they are only predicted at the equivocal absolute reasoning level, which is much too low for that particular biotransformation in humans. N-acetylations are heavily overpredicted, whereas N-oxidations at morpholine and piperidine rings are underpredicted, again for this test set.
The reactivity correction provides the best results when set at on for substrate, thus without considering the reaction mechanism of the P450 enzyme. One would expect more precision of the prediction profile in MetaSite considering the P450 mechanism additionally, but, surprisingly, this is not the case. Sometimes MetaSite identifies an in silico SOM right next to what the in vivo results indicate as a SOM. The fine tuning of relative distances inside the active site of virtual P450 enzymes could possibly help to resolve this problem. In Metasite, too, some important aliphatic/aromatic hydroxylations that were seen for the test set are not predicted.
For StarDrop, one cannot attach much value to the absolute factor in the metabolism prediction because it does not correlate with the in vivo abundance of metabolism, irrespective of the terminology labile positions, stable positions, etc. N-oxidations and some aliphatic hydroxylations, in our case, were not predicted by StarDrop.
Conclusion. In this study, we have evaluated and compared the metabolite prediction software packages Meteor, MetaSite, and StarDrop, in terms of precision and sensitivity. We conclude that the state-of-the-art individual metabolite prediction software has many advantageous features but still needs refinement to obtain an acceptably useful prediction profile. We found that intelligent combinations, i.e., combining packages based on different mechanistic principles, could prove useful and should be pursued to increase the prediction precision. Depending on the scope of the intended research, either sensitivity or precision should be prioritized. The answer to "what will happen" in drug metabolism should be sought in precise prediction tools; the answer to "what might happen" in drug metabolism should be sought in sensitive prediction tools.
